Eli Lilly

Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Tesla Investor Ross Gerber Backs Ozempic's Potential To Reduce Monthly Food Expenses — Less Eating, More Saving
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
Tesla Investor Ross Gerber Backs Ozempic's Potential To Reduce Monthly Food Expenses — Less Eating, More Saving
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
Jim Cramer Warns Weight Loss Drugs Ozempic, Wegovy And Others Could Impact Food Stocks: 'That Day Will Come'
Apple, Chipotle And Eli Lilly Stocks Baffle Jim Cramer With Unusual Moves: 'Authentic Stupidity Is A Perfectly Plausible Explanation'

Eli Lilly Recent News

QuantumScape, Peloton, Eli Lilly, Walgreens, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stock markets gave a mixed picture on Thursday with the Dow Jones inching up 0.03% to 37,440.34.
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.
Eli Lilly's Stock Spikes, Yet Team Jim Cramer Holds Back On Recommending Immediate Buying: 'Wait For A Pullback'
Ozempic Overshadowed As Eli Lilly's Retatrutide Promises Unprecedented Weight Loss: Bloomberg
Twitter Blue Account Declares Eli Lilly Giving Away Free Insulin, Pharma Giant Says Its Fake
A fake account with the handle @EliLillyandCo posted last week on Twitter that Eli Lilly And Co (NYSE: LLY) is giving away free insulin. 
The Latest Barron's Picks And Pans: DocuSign, UPS, Taiwan Semiconductor And More
The cover story in this weekend's Barron's examines how teenage traders are shaking up the market. Other featured articles discuss which drugmakers benefit from a new market, why it is time to buy momentum stocks and how to safely hunt for yield.
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial public offerings. A couple of chief executive officers were among the insiders buying shares this past week.
Barron's Latest Picks And Pans: Space Race Picks, Eli Lilly, GameStop, Splunk And More
This weekend's Barron's cover story discusses ways to play the space race as the industry flourishes.
Barron's Picks And Pans: Amazon, Biogen, Casey's General Stores, Hilton And More
This weekend's Barron's cover story discusses a coming Alzheimer's crisis. Other featured articles discuss whether utilities are worth another look, which real estate investment trusts to focus on and how to play rising platinum prices.
Benzinga's Weekly Bulls And Bears: Eli Lilly, Ford, GameStop, Intel, McDonald's And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. The week's bullish calls included aerospace, automaker and pharmaceutical giants. A leading semiconductor maker and a struggling retailer were among the bearish calls.
Benzinga's Bulls And Bears Of The Week: Apple, Disney, Intel And More
Benzinga's Bulls & Bears Of The Week: Caterpillar, Facebook, Starbucks, Tesla And More
Benzinga's Weekly Bulls & Bears: Apple, Eli Lilly, GE, Nike And More
Barron's Sees Dow At 30,000
Eli Lilly's Guidance Supported By Short-Term Boosts, Not Better Fundamentals
Eli Lilly Announces Guidance, U.S. Insulin Release
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Eli Lilly Says It Will Launch 20 New Products Through 2023
Big Biotech In The Earnings Spotlight
Facebook And Amazon: More Earnings From The FANG Stocks
Chrysler And Ford Earnings: Following In GM's Footsteps?
GM And GE: Will Revitalization Efforts Pay Out In Earnings?
McDonald's Vs. Starbucks: Which Earnings Will Be Tastier?